Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Conference News THT 2025

Positive Results With Carillon Mitral Device Seen in Real-world Registries

Todd Neale

February 21, 2025

News Conference News THT 2025

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

Todd Neale

February 18, 2025

Presentation THT 2025

Impact of Barostim Therapy on Atrial Fibrillation Burden: A Retrospective Single-Center Study

Presenter: Hata Mujadzic

February 11, 2025

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

Presentation THT 2024

IV Diltiazem Use in Patients with Atrial Fibrillation and Systolic Dysfunction

Presenter: Joseph Ibrahim

March 05, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Conference News THT 2023

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

Shelley Wood

March 24, 2023

News Conference News THT 2023

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Yael L. Maxwell

March 22, 2023

News Conference News THT 2023

Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry

Caitlin E. Cox

March 21, 2023

News Conference News THT 2022

PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients

L.A. McKeown

February 03, 2022

Presentation THT 2022

The Effect of Rhythm vs. Rate Control for Atrial Fibrillation on Mortality and Hospitalization in Patients With Heart Failure With Preserved Ejection Fraction: Updated Meta-Analysis

Presenter: Mohammed Al-Sadawi

February 01, 2022

Advertisement

Positive Results With Carillon Mitral Device Seen in Real-world Registries

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

Impact of Barostim Therapy on Atrial Fibrillation Burden: A Retrospective Single-Center Study

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

IV Diltiazem Use in Patients with Atrial Fibrillation and Systolic Dysfunction

Debating the Role of T-TEER in the Sickest Patients

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry

PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients

The Effect of Rhythm vs. Rate Control for Atrial Fibrillation on Mortality and Hospitalization in Patients With Heart Failure With Preserved Ejection Fraction: Updated Meta-Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content